Merck allocates three million courses of Molnupiravir to be provided in first half of 2022 for use…
Merck is developing Molnupiravir in collaboration with Ridgeback Biotherapeutics and it has been authorised for use in more than…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Fourth COVID vaccine partially effective against Omicron: Israeli study
The yet-to-be peer-reviewed study tested the efficacy and safety of vaccines and analysed whether the combination of vaccines from…
Stempeutics gets DCGI nod for phase-III clinical trial on its product for treating COVID patients
The company will be using its stem cell product, Stempeucel, for conducting the label extension phase-III clinical trial
COVID treatment: Centre issues revised guidelines on use of drugs and therapies
The revised guidelines continue to recommend Emergency Use Authorisation (EUA) or off-label use of Remdesivir in patients with…
Strides Pharma’s Singapore arm gets US FDA nod for generic version of oseltamivir phosphate
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Tamiflu for oral suspension, 6…
Atrimed Pharmaceuticals introduces capsule that can inhibit viral replication
The formulation has been tested against the Delta variant and was found to be effective. AI-based studies prove that it is also…
MSF provides free telemedicine consultation for COVID-19 patients in India
MSF doctors and nurses are available on the toll-free helpline 24 hours a day and seven days a week, and will conduct…
Pharma Budget 2022
Pharma leaders and experts share their concerns about the industry, and expectations from Budget 2022
Ono Pharma expands drug discovery collaboration with Neurimmune AG
The collaboration focusses on creating antibody drugs against new therapeutic targets in the field of neurodegenerative diseases…
US FDA grants priority review to Daiichi Sankyo and AstraZeneca’s sBLA of Enhertu
Enhertu is a HER2-directed Antibody Drug Conjugate (ADC) being jointly developed by Daiichi Sankyo and AstraZeneca for treatment…
Pfizer to boost COVID-19 pill production with French deal
The decision is part of Pfizer's strategy to boost global production of the pill, Paxlovid, which was found to be nearly 90 per…
Moderna CEO says data for Omicron-specific shot likely available in March
"The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to…
Menarini appoints Girisan Kariangal as India Managing Director
Girisan has replaced Anandh Balasundaram who will be retiring from the company within the next few months
IIT Mandi researchers discover phytochemicals in Himalayan plant that inhibit COVID-19 virus
Researchers show that phytochemical-rich petals of Rhododendron arboreum found in the Himalayan region, locally called “Buransh”…
WHO recommends two new drugs to treat COVID-19
The extent to which these medicines, Baricitinib and Sotrovimab, will save lives depends on how widely available and affordable…
Gilead withdraws use of Zydelig to treat cancer
The US FDA gave the drug an accelerated approval to treat relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small…
J&J reaches opioid settlement with holdout state New Mexico
Under the accord, J&J agreed to pay New Mexico its share of the nationwide settlement in 2022, rather than over several years,…
US FDA approves drugs from AbbVie and Pfizer to treat eczema
AbbVie’s Rinvoq and Pfizer’s Cibinqo have been approved to treat moderate-to-severe eczema, in patients who do not respond to…
Aurobindo Pharma gets warning letter from US FDA for API facility
The action follows the recent inspection of the facility by the US Food and Drug Administration (FDA) in August 2021, the…
Ministry of AYUSH observes ‘Surya Namaskar for vitality’
More than 75 lakh people from all over the world, including India, performed Surya Namaskar together to keep the body and mind…